The Drugs Controller General of India has given approval to Serum Institute of India, Pune to conduct Phase IIIII clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India.<br />''<br />''This will hasten the development of the COVID-19 vaccine. Union Health Ministry said, India continues to improve the Case Fatality Rate (CFR), and maintain its global position of having one of the lowest COVID fatalities rates.<br />''<br />''With a further fall, the current CFR touched 2.11 per cent today.<br />''<br />''The management strategy of COVID-19 also focuses on early detection and isolation of cases with seamless patient management and prioritising care of the high-risk population, leading to increase in recoveries across the country.<br />''<br />''The Ministry said, India has seen more than 40,574 patients recovered in the last 24 hours.<br />''<br />''This takes the total recoveries to 11,86,203 and recovery rate to 65.77 per cent amongst COVID-19 patients.<br />''<br />''With improving daily recovery number, the gap between the recovered cases and the active cases has increased to more than 6 lakh.<br />''<span style="color: #222222;">The actual active case load is over 5,79,000 and all are under medical supervision.</span>